Mereo BioPharma (MREO) Exchange Rate Effect (2023 - 2026)
Mereo BioPharma (MREO) posted quarterly Exchange Rate Effect of -$157000.0 for Q1 2026, down 117.29% year-on-year from $908000.0 in Q1 2025, and down 149.21% on a QoQ basis from -$63000.0 in Q4 2025.
Mereo BioPharma (MREO) Exchange Rate Effect (2023 - 2026) Analysis & Trends
Mereo BioPharma (MREO) has reported Exchange Rate Effect for 4 consecutive years, with -$157000.0 the latest figure, recorded in Q1 2026.
- Quarterly Exchange Rate Effect fell 117.29% year-over-year to -$157000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $789000.0 (up 5.91% YoY) and the FY2025 annual result came in at $1.9 million, up 895.71% from the prior year.
- Exchange Rate Effect retreated to -$157000.0 in Q1 2026 per MREO's latest filing, from -$63000.0 in the prior quarter.
- Over the last five years, Exchange Rate Effect for MREO reached as high as $1.7 million in Q4 2023 and fell as low as -$1.3 million in Q4 2024.
- A 4-year average of $329384.6 and a median of -$63000.0 in 2025 frame the typical range for Exchange Rate Effect.
- Annual changes were most pronounced in 2024 — Exchange Rate Effect sank 174.91% — and 2025, when it soared 1433.64%.
- Year by year, Exchange Rate Effect stood at $1.7 million in 2023, then plunged by 174.91% to -$1.3 million in 2024, then jumped by 95.0% to -$63000.0 in 2025, then sank by 149.21% to -$157000.0 in 2026.
- According to Business Quant data, Exchange Rate Effect over the past three periods registered -$157000.0, -$63000.0, and -$418000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 619,347.27 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 19.32 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 14,631.83 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | -40.30 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -900,000.00 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Mereo BioPharma | 232.52 Mn | 232.52 Mn | - | -157,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -157,000.00 |
| Mar 31, 2026 | -157,000.00 |
| Dec 31, 2025 | -63,000.00 |
| Dec 31, 2025 | -63,000.00 |
| Sep 30, 2025 | -418,000.00 |
| Sep 30, 2025 | -418,000.00 |
| Jun 30, 2025 | 1.43 Mn |
| Jun 30, 2025 | 1.43 Mn |
| Mar 31, 2025 | 908,000.00 |
| Mar 31, 2025 | 908,000.00 |
| Dec 31, 2024 | -1.26 Mn |
| Dec 31, 2024 | -1.26 Mn |
| Sep 30, 2024 | 1.20 Mn |
| Sep 30, 2024 | 1.20 Mn |
| Jun 30, 2024 | -107,000.00 |
| Jun 30, 2024 | -107,000.00 |
| Mar 31, 2024 | -70,000.00 |
| Mar 31, 2024 | -70,000.00 |
| Dec 31, 2023 | 1.68 Mn |
| Dec 31, 2023 | 1.68 Mn |